Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease.

Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. Am J Gastroenterol. 2003 Apr; 98(4):833-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.